Video

Interview with Ahmed Mousa - The new CEO of Vicore Pharma

Pareto Securities 13 Sep 2023 18:04

We interviewed Vicore's new CEO, Ahmed Mousa, on his background, why he joined Vicore, and his plans and visions for Vicore.

He shared his multidisciplinary background, including the biology tackled by Vicore's scientific platform. He also shared his thoughts on idiopathic pulmonary fibrosis as a disease and treatment landscape and C21's mechanism and clinical data. The information in this video should not be seen as an investment advice. Keep in mind that investments in securities always carry a risk.

Historical returns are no guarantee of future returns. The money invested in securities can both increase and decrease in value and there is no guarantee that you will get back the amount invested. It is important to continuously monitor your holdings and if necessary take actions to reduce the risk of loss.

http://share.paretosec.com/download/compliance/disclaimer.pdf.

Videon i sin helhet

•Denna källa tillämpar ofta läsvägg för sina artiklar

Se hela klippet

Börskollens app – Högt betyg ⭐⭐⭐⭐⭐ och 250.000 nedladdningar

Ladda hem

Vårt nyhetsbrev – Utvalda börsnyheter och heta investeringscase varje vecka

Prenumerera

Nyheter om Vicore Pharma

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!